What Generex needs to do is actually show data. We’ve had press releases, including one for a non scientific trademark, and words in conference calls. We don’t have peer reviewed data like other companies including a review for a multi epitope peptide vaccine that I looked at earlier.
We need that to actually occur.
(5)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links